Figure 1 3,4-Difluorobenzocurcumin treatment inhibits trunk and facial lymphatic development in zebrafish. (A?D) Lateral fluorescent images of 6 dpf Tg(-5.2lyve1b:DsRed2) larvae treated with either 0.1% DMSO (A), 20 ?M sunitinib malate (SM, B), 10 ?M curcumin (CM, C), or 2.5 ?M 3,4-Difluorobenzocurcumin (CDF, D). CDF inhibits lymphatic development in a dose-dependent manner in zebrafish. (E) Quantification of somites with thoracic duct (TD) tissue fragments in 6 dpf Tg(-5.2lyve1b:DsRed2) larvae treated with either 0.1% DMSO (n = 49 larvae), 20 ?M SM (n = 51 larvae), 10 ?M CM (n = 32 larvae), or CDF at 0.5 ?M (n = 34 larvae), 1 ?M (n = 37 larvae), 2.5 ?M (n = 48 larvae), or 5 ?M (n = 46 larvae). (F?H?) Lateral confocal images of 5 dpf Tg(fli1a:nEGFP);Tg(-5.2lyve1b:DsRed2) larvae treated with either 0.1% DMSO (F,F?), 10 ?M CRM (G,G?), or 2.5 ?M CDF (H,H?). Images (F??H?) represent the Tg(-5.2lyve1b:DsRed2) expression of images (F?H). (I,J) Quantification of TD (I) or dorsal longitudinal lymphatic vessel (DLLV, J) nuclei across 9 somites in 5 dpf Tg(fli1a:nEGFP);Tg(-5.2lyve1b:DsRed2) larvae treated with either 0.1% DMSO (n = 20 larvae), 10 ?M CM (n = 20 larvae), or 2.5 ?M CDF (n = 24 larvae). (K) Quantification of somites with intersegmental vessels (ISVs) in 48 hpf Tg(fli1a:EGFP) embryos treated with either 0.1% DMSO (n = 47 embryos), 20 ?M SM (n = 56 embryos), or CDF at 2.5 ?M (n = 35 embryos), 5 ?M (n = 39 embryos), or 10 ?M (n = 27 embryos). CDF at 2.5 ?M does not inhibit primary angiogenesis. Representative fluorescent images of graph K can be found in Figure S2A?E. (L?O?) Lateral confocal images of Tg(fli1a:nEGFP);Tg(-5.2lyve1b:DsRed2) larvae treated with either 0.1% DMSO (L,L?), 20 ?M SM (M,M?), 10 ?M CM (N,N?), or 2.5 ?M CDF (O,O?). CDF at 2.5 ?M blocks facial lymphatic development. Images (L??O?) represent the Tg(-5.2lyve1b:DsRed2) expression of images (L?O). (P?R) Quantification of lateral facial lymphatic (LFL, P), medial facial lymphatic (MFL, Q), or otolithic lymphatic vessel (OLV, R) nuclei in 5 dpf Tg(fli1a:nEGFP);Tg(-5.2lyve1b:DsRed2) larvae treated with either 0.1% DMSO (n = 14 larvae), 20 ?M SM (n = 16 larvae), 10 ?M CM (n = 14 larvae), or 2.5 ?M CDF (n = 15 larvae). Statistical test: Kruskal-Wallis test were conducted for graphs (E,I?K,P?R). PCV: posterior cardinal vein. p ? 0.001 (***) and n.s. indicates not significant. Scale bars: 100 ?m.
Image
Figure Caption
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ Pharmaceuticals (Basel)